Lisata Therapeutics (8NE) Cash flow

0 Followers

Lisata Therapeutics Cash Flow

DE:8NE's free cash flow for Q2 2026 was $-2.65M. For the 2026 fiscal year, DE:8NE's free cash flow was decreased by $3.38M and operating cash flow was $-2.65M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -15.95M	$ -19.36M	$ -20.03M	$ -21.17M	$ -22.25M
Investing Cash Flow	$ 15.09M	$ 13.23M	$ 10.10M	$ 28.91M	$ -54.90M
Financing Cash Flow	$ 599.00K	$ -206.00K	$ 385.00K	$ -224.00K	$ 85.28M
End Cash Position	$ 15.96M	$ 16.21M	$ 22.59M	$ 32.15M	$ 24.65M
Free Cash Flow	$ -15.98M	$ -19.36M	$ -20.03M	$ -21.45M	$ -22.30M

Currency in USD